BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28888722)

  • 1. Breast Cancer Risk After Radiation Therapy for Hodgkin Lymphoma: Influence of Gonadal Hormone Exposure.
    Krul IM; Opstal-van Winden AWJ; Aleman BMP; Janus CPM; van Eggermond AM; De Bruin ML; Hauptmann M; Krol ADG; Schaapveld M; Broeks A; Kooijman KR; Fase S; Lybeert ML; Zijlstra JM; van der Maazen RWM; Kesminiene A; Diallo I; de Vathaire F; Russell NS; van Leeuwen FE
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):843-853. PubMed ID: 28888722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.
    Travis LB; Hill D; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Pukkala E; Lynch CF; Pee D; Smith SA; Van't Veer MB; Joensuu T; Storm H; Stovall M; Boice JD; Gilbert E; Gail MH
    J Natl Cancer Inst; 2005 Oct; 97(19):1428-37. PubMed ID: 16204692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary Breast Cancer Risk by Radiation Volume in Women With Hodgkin Lymphoma.
    Conway JL; Connors JM; Tyldesley S; Savage KJ; Campbell BA; Zheng YY; Hamm J; Pickles T
    Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):35-41. PubMed ID: 27979454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease.
    van Leeuwen FE; Klokman WJ; Stovall M; Dahler EC; van't Veer MB; Noordijk EM; Crommelin MA; Aleman BM; Broeks A; Gospodarowicz M; Travis LB; Russell NS
    J Natl Cancer Inst; 2003 Jul; 95(13):971-80. PubMed ID: 12837833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease.
    Travis LB; Hill DA; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Wiklund T; Lynch CF; Van't Veer MB; Glimelius I; Storm H; Pukkala E; Stovall M; Curtis R; Boice JD; Gilbert E
    JAMA; 2003 Jul; 290(4):465-75. PubMed ID: 12876089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy-Related Dose and Irradiated Volume Effects on Breast Cancer Risk Among Hodgkin Lymphoma Survivors.
    Roberti S; van Leeuwen FE; Ronckers CM; Krul IM; de Vathaire F; Veres C; Diallo I; Janus CPM; Aleman BMP; Russell NS; Hauptmann M
    J Natl Cancer Inst; 2022 Sep; 114(9):1270-1278. PubMed ID: 35771630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.
    De Bruin ML; Sparidans J; van't Veer MB; Noordijk EM; Louwman MW; Zijlstra JM; van den Berg H; Russell NS; Broeks A; Baaijens MH; Aleman BM; van Leeuwen FE
    J Clin Oncol; 2009 Sep; 27(26):4239-46. PubMed ID: 19667275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic features of breast cancers diagnosed in women treated with prior radiation therapy for Hodgkin lymphoma: Results from a population-based cohort.
    Wong SM; Ajjamada L; Weiss AC; Prakash I; Skamene S; Boileau JF; Pollak MN; Basik M
    Cancer; 2022 Apr; 128(7):1365-1372. PubMed ID: 34919263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Radiation and Procarbazine Dose With Risk of Colorectal Cancer Among Survivors of Hodgkin Lymphoma.
    Geurts YM; Shakir R; Ntentas G; Roberti S; Aznar MC; John KM; Ramroth J; Janus CPM; Krol ADG; Roesink JM; van der Maazen RWM; Zijlstra JM; Darby SC; Aleman BMP; van Leeuwen FE; Cutter DJ; Schaapveld M
    JAMA Oncol; 2023 Apr; 9(4):481-489. PubMed ID: 36729438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian reserve after treatment with alkylating agents during childhood.
    Thomas-Teinturier C; Allodji RS; Svetlova E; Frey MA; Oberlin O; Millischer AE; Epelboin S; Decanter C; Pacquement H; Tabone MD; Sudour-Bonnange H; Baruchel A; Lahlou N; De Vathaire F
    Hum Reprod; 2015 Jun; 30(6):1437-46. PubMed ID: 25801499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic susceptibility to radiation-induced breast cancer after Hodgkin lymphoma.
    Opstal-van Winden AWJ; de Haan HG; Hauptmann M; Schmidt MK; Broeks A; Russell NS; Janus CPM; Krol ADG; van der Baan FH; De Bruin ML; van Eggermond AM; Dennis J; Anton-Culver H; Haiman CA; Sawyer EJ; Cox A; Devilee P; Hooning MJ; Peto J; Couch FJ; Pharoah P; Orr N; Easton DF; Aleman BMP; Strong LC; Bhatia S; Cooke R; Robison LL; Swerdlow AJ; van Leeuwen FE
    Blood; 2019 Mar; 133(10):1130-1139. PubMed ID: 30573632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.
    Haberer S; Belin L; Le Scodan R; Kirova YM; Savignoni A; Stevens D; Moisson P; Decaudin D; Pierga JY; Reyal F; Campana F; Fourquet A; Bollet MA
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e145-52. PubMed ID: 21605948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy.
    van den Belt-Dusebout AW; Aleman BM; Besseling G; de Bruin ML; Hauptmann M; van 't Veer MB; de Wit R; Ribot JG; Noordijk EM; Kerst JM; Gietema JA; van Leeuwen FE
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1420-9. PubMed ID: 19931732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin's lymphoma: a multi-institutional, matched cohort study.
    Elkin EB; Klem ML; Gonzales AM; Ishill NM; Hodgson D; Ng AK; Marks LB; Weidhaas J; Freedman GM; Miller RC; Constine LS; Myrehaug S; Yahalom J
    J Clin Oncol; 2011 Jun; 29(18):2466-73. PubMed ID: 21576642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors.
    van Eggermond AM; Schaapveld M; Janus CP; de Boer JP; Krol AD; Zijlstra JM; van der Maazen RW; Kremer LC; van Leerdam ME; Louwman MW; Visser O; De Bruin ML; Aleman BM; van Leeuwen FE
    Br J Cancer; 2017 Jul; 117(3):306-314. PubMed ID: 28632726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors.
    Hill DA; Gilbert E; Dores GM; Gospodarowicz M; van Leeuwen FE; Holowaty E; Glimelius B; Andersson M; Wiklund T; Lynch CF; Van't Veer M; Storm H; Pukkala E; Stovall M; Curtis RE; Allan JM; Boice JD; Travis LB
    Blood; 2005 Nov; 106(10):3358-65. PubMed ID: 16051739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin's lymphoma.
    Lee L; Pintilie M; Hodgson DC; Goss PE; Crump M
    Ann Oncol; 2008 Jan; 19(1):62-7. PubMed ID: 17878177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease.
    van Leeuwen FE; Klokman WJ; Stovall M; Hagenbeek A; van den Belt-Dusebout AW; Noyon R; Boice JD; Burgers JM; Somers R
    J Natl Cancer Inst; 1995 Oct; 87(20):1530-7. PubMed ID: 7563187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast Imaging in Women Previously Irradiated for Hodgkin Lymphoma.
    Horst KC; Fero KE; Hancock SL; Advani RH; Ikeda DM; Daniel B; Rosenberg SA; Donaldson SS; Hoppe RT
    Am J Clin Oncol; 2016 Apr; 39(2):114-9. PubMed ID: 24390271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study.
    Sklar CA; Mertens AC; Mitby P; Whitton J; Stovall M; Kasper C; Mulder J; Green D; Nicholson HS; Yasui Y; Robison LL
    J Natl Cancer Inst; 2006 Jul; 98(13):890-6. PubMed ID: 16818852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.